Ad hominem
Overview[edit]

The term ad hominem is a Latin phrase that translates to "to the person." In the context of argumentation and rhetoric, an ad hominem argument is one that attacks the character or personal traits of an opponent rather than engaging with the substance of their argument. This type of argument is considered a logical fallacy because it does not address the actual issue at hand, but rather diverts attention to irrelevant personal characteristics.
Historical Context[edit]
The concept of ad hominem arguments can be traced back to ancient Greek philosophy, where philosophers like Aristotle and Socrates discussed the importance of logical reasoning and the pitfalls of fallacious arguments. Aristotle, in particular, categorized various types of logical fallacies in his works, such as the "Sophistical Refutations."
Types of Ad Hominem[edit]
Ad hominem arguments can take several forms, including:
- Abusive ad hominem: This involves direct attacks on an individual's character, intelligence, or appearance.
- Circumstantial ad hominem: This occurs when an argument is dismissed based on the circumstances or interests of the person making it.
- Tu quoque: This form of ad hominem accuses the opponent of hypocrisy, suggesting that their argument is invalid because they do not practice what they preach.
Examples in Debate[edit]
In a debate, an ad hominem argument might look like this:
- Person A: "We should implement stricter environmental regulations to combat climate change."
- Person B: "You can't trust Person A's opinion on this matter; they drive a gas-guzzling SUV."
In this example, Person B attacks Person A's personal behavior rather than addressing the argument about environmental regulations.
Criticism and Impact[edit]
Ad hominem arguments are criticized for undermining rational discourse. They shift the focus from the merits of the argument to the personal attributes of the individual, which can lead to a breakdown in constructive dialogue. In academic and professional settings, reliance on ad hominem attacks is generally seen as a sign of weak argumentation.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian